Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

K Matthay

Showing results (131-140 of 316) with videos related to

Pageof 32
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 1, 1995
Phase I trial of 13-cis-retinoic acid in children with neuroblastoma following bone marrow transplantationJ G Villablanca, A A Khan, V I Avramis, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|June 15, 2019
Risk Factors for Transplant-Associated Thrombotic Microangiopathy after Autologous Hematopoietic Cell Transplant in High-Risk NeuroblastomaVanessa P Tolbert, Christopher C Dvorak, Carla Golden, et al.
Cancer Research|October 1, 2024
Editor's Note: Inhibition of Phosphatidylinositol 3-Kinase Destabilizes Mycn Protein and Blocks Malignant Progression in NeuroblastomaLouis Chesler, Chris Schlieve, David D Goldenberg, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 24, 2005
Favorable prognosis for patients 12 to 18 months of age with stage 4 nonamplified MYCN neuroblastoma: a Children's Cancer Group StudyMary Lou Schmidt, Ashutosh Lal, Robert C Seeger, et al.
Cancer|July 2, 2003
Central nervous system metastases in neuroblastoma: radiologic, clinical, and biologic features in 23 patientsKatherine K Matthay, Hervé Brisse, Dominique Couanet, et al.
British Journal of Cancer|January 21, 2015
Phase I/II study of (131)I-MIBG with vincristine and 5 days of irinotecan for advanced neuroblastomaS G DuBois, S Allen, M Bent, et al.
Cancer Medicine|December 14, 2020
Association of image-defined risk factors with clinical features, histopathology, and outcomes in neuroblastomaWilliam C Temple, Kieuhoa T Vo, Katherine K Matthay, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 16, 2004
Hematologic toxicity of high-dose iodine-131-metaiodobenzylguanidine therapy for advanced neuroblastomaSteven G DuBois, Julia Messina, John M Maris, et al.
Medical and Pediatric Oncology|December 7, 2000
Multidrug resistance-associated protein 1 (MRP1) expression in neuroblastoma cell lines and primary tumorsH Goto, N Keshelava, K K Matthay, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|November 7, 2001
Correlation of tumor and whole-body dosimetry with tumor response and toxicity in refractory neuroblastoma treated with (131)I-MIBGK K Matthay, C Panina, J Huberty, et al.
Pageof 32

Showing results (131-140 of 316) with videos related to

Sort By:
Pageof 32
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 1, 1995
Phase I trial of 13-cis-retinoic acid in children with neuroblastoma following bone marrow transplantationJ G Villablanca, A A Khan, V I Avramis, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|June 15, 2019
Risk Factors for Transplant-Associated Thrombotic Microangiopathy after Autologous Hematopoietic Cell Transplant in High-Risk NeuroblastomaVanessa P Tolbert, Christopher C Dvorak, Carla Golden, et al.
Cancer Research|October 1, 2024
Editor's Note: Inhibition of Phosphatidylinositol 3-Kinase Destabilizes Mycn Protein and Blocks Malignant Progression in NeuroblastomaLouis Chesler, Chris Schlieve, David D Goldenberg, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 24, 2005
Favorable prognosis for patients 12 to 18 months of age with stage 4 nonamplified MYCN neuroblastoma: a Children's Cancer Group StudyMary Lou Schmidt, Ashutosh Lal, Robert C Seeger, et al.
Cancer|July 2, 2003
Central nervous system metastases in neuroblastoma: radiologic, clinical, and biologic features in 23 patientsKatherine K Matthay, Hervé Brisse, Dominique Couanet, et al.
British Journal of Cancer|January 21, 2015
Phase I/II study of (131)I-MIBG with vincristine and 5 days of irinotecan for advanced neuroblastomaS G DuBois, S Allen, M Bent, et al.
Cancer Medicine|December 14, 2020
Association of image-defined risk factors with clinical features, histopathology, and outcomes in neuroblastomaWilliam C Temple, Kieuhoa T Vo, Katherine K Matthay, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 16, 2004
Hematologic toxicity of high-dose iodine-131-metaiodobenzylguanidine therapy for advanced neuroblastomaSteven G DuBois, Julia Messina, John M Maris, et al.
Medical and Pediatric Oncology|December 7, 2000
Multidrug resistance-associated protein 1 (MRP1) expression in neuroblastoma cell lines and primary tumorsH Goto, N Keshelava, K K Matthay, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|November 7, 2001
Correlation of tumor and whole-body dosimetry with tumor response and toxicity in refractory neuroblastoma treated with (131)I-MIBGK K Matthay, C Panina, J Huberty, et al.
Pageof 32